Moneycontrol PRO
HomeNewsBusinessMarketsStock Radar: Welspun Enterprises, Zomato, BSE, Apollo Hospitals, Biocon, Lupin in focus on Monday

Stock Radar: Welspun Enterprises, Zomato, BSE, Apollo Hospitals, Biocon, Lupin in focus on Monday

IDFC First Bank, Dr Reddy’s Laboratories, Punjab National Bank, ICICI Prudential Life Insurance Company, Bharat Electronics, Tata Chemicals, Adani Enterprises, and Adani Energy Solutions will also be in focus on September 30.

September 29, 2024 / 21:43 IST
Stocks in news

Stocks in news

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Let's catch up on the latest news from the stock market. From significant investments to major deals, fund raising and appointments, here’s a quick look at which stocks will be in focus in today's trade:

Stocks To Watch

Welspun Enterprises

The company has been declared the L1 bidder by the Brihanmumbai Municipal Corporation (BMC) for a project worth Rs 1,989.9 crore. The project involves the design and construction of an 8.48 km tertiary treated water conveyance tunnel from the Dharavi WWTF to the Ghatkopar WWTF, to be executed within a period of 93 months.

IDFC First Bank

The board has approved the amalgamation of IDFC Financial Holding Company with IDFC, effective September 30, and the merger of IDFC with IDFC First Bank, effective October 1. Furthermore, the board has appointed V Vaidyanathan as MD & CEO of the bank for three years, effective from December 19, 2024.

Dr Reddy’s Laboratories

The pharmaceutical company has invested $620 million in preference shares of its subsidiary Dr Reddy’s Laboratories SA, Switzerland. The subsidiary has allotted 6.2 million non-convertible preference shares, each with a nominal value of $100, to the company.

Zomato

Zomato's co-founder and Chief People Officer, Akriti Chopra, has resigned with immediate effect after a 13-year-long tenure at the food delivery company.

Punjab National Bank

The state-run lender has raised Rs 5,000 crore via Qualified Institutions Placement (QIP). It has approved the allotment of 48.19 crore shares to eligible qualified institutional buyers at a price of Rs 103.75 per share, including Citigroup Global Markets Mauritius - ODI, BOFA Securities Europe SA - ODI, SBI Contra Fund, Morgan Stanley Asia (Singapore), and Goldman Sachs.

ICICI Prudential Life Insurance Company

The company has received an order from the Assistant Commissioner of Income Tax, Mumbai, demanding tax and interest of Rs 361.23 crore for the Assessment Year 2022-23. The company plans to file an appeal against the order before the Commissioner (Appeals).

BSE

The exchange has revised its transaction charges for Sensex and Bankex Options (for all expiries) to Rs 3,250 per crore of premium turnover value, effective October 1. However, there will be no changes in the transaction charges for other contracts in the equity derivatives segment.

Apollo Hospitals Enterprise

The board of Apollo Healthco has approved the allotment of Rs 2,475 crore worth of compulsorily convertible non-cumulative participating preference shares (CCPS - Class A and B) with a face value of Rs 100 per share, to Rasmeli, an Advent affiliate, for a 16.9% stake. Following the allotment, Apollo Hospitals' stake in its subsidiary, Apollo Healthco, will reduce from 94.91% to 78.879%.

Bharat Electronics

The Ministry of Corporate Affairs (MCA) has approved the incorporation of BEL IAI AeroSystems, a joint venture between Bharat Electronics and Israel Aerospace Industries, Israel.

Tata Chemicals

The company has appointed Subodh Srivastav as Chief Marketing Officer, effective October 21, 2024.

Adani Enterprises

April Moon Retail, a joint venture company of Adani Airport Holdings, has executed a Share Purchase Agreement with Cococart Ventures (CVPL) and its existing shareholders, Karan Ahuja and Arjun Ahuja, for the acquisition of a 74% stake in CVPL for Rs 200 crore. Adani Airport Holdings is a subsidiary of Adani Enterprises.

Adani Energy Solutions

Adani Electricity Mumbai has signed a Business Transfer Agreement with its subsidiary, North Maharashtra Power, to carve out the Adani Dahanu Thermal Power Station. Adani Electricity Mumbai is a subsidiary of Adani Energy Solutions.

LTIMindtree

The technology consulting and digital solutions company has strengthened its partnership with Currys, the UK retailer of technology products and services. LTIMindtree will re-platform Currys' website to Salesforce Commerce Cloud, launch an in-store client app on Experience Cloud, and implement Service Cloud for post-sales support.

IndusInd Bank

The board has approved the re-appointment of Sumant Kathpalia as Managing Director & CEO for a term of three years, effective March 24, 2025. This re-appointment is subject to approval by the Reserve Bank of India and the bank's shareholders.

Mangalore Chemicals and Fertilizers

The company has resumed production at its ammonia and urea plants. Both plants were shut down for the replacement of reformer catalysts on September 6.

Mahanagar Gas

Life Insurance Corporation of India (LIC) has reduced its stake in the natural gas distribution company by 2.091%, bringing its holding down from 9.03% to 6.939% during the period of September 12–26, 2024.

Asian Energy Services

The company has received a contract worth Rs 82 crore from Oil India for 2D seismic data acquisition of 4,300 LKM in the Rajasthan Basin under Mission Anveshan. The order will be executed within 18 months, and the company’s total order book now stands at Rs 1,000 crore.

Piramal Pharma

The US Food and Drug Administration (FDA) has issued an Establishment Inspection Report for the company’s manufacturing facility in Ahmedabad. On July 12, the FDA issued zero Form-483 observations, with a "No Action Indicated" (NAI) designation after the inspection.

Jubilant Pharmova

The US FDA has classified the inspection of Jubilant HollisterStier General Partnership's contract manufacturing facility in Canada as "Official Action Indicated" (OAI). This audit was originally reported on June 18. Jubilant HollisterStier General Partnership is a subsidiary of Jubilant HollisterStier Inc, USA, which is itself a step-down subsidiary of Jubilant Pharma, Singapore, wholly owned by Jubilant Pharmova.

Biocon

The US FDA has issued four observations regarding the company’s API facility (Site 2) in Bengaluru. The facility was inspected between September 23 and September 27. The company does not anticipate any significant impact on its business.

Lupin

The US FDA concluded an inspection of Lupin's Pithampur Unit-1 API and finished product manufacturing facility with three observations each for both the API and finished product operations. The facility was inspected from September 16 to September 27.

MPS

The company has appointed Prarthana Agarwal as Chief Financial Officer, effective October 1, following the retirement of Sunit Malhotra from the same role.

Tata Motors

Tata Motors Group held the groundbreaking ceremony for its new vehicle manufacturing facility in Tamil Nadu. The group plans to invest Rs 9,000 crore in this greenfield manufacturing facility, which is designed for an annual production capacity of over 2.5 lakh vehicles. Production will begin in phases and progressively ramp up to full capacity over the next 5-7 years.

Reliance Infrastructure

The Calcutta High Court has ruled in favour of Reliance Infrastructure, upholding the arbitration award of Rs 780 crore (including accrued interest) against West Bengal-based Damodar Valley Corporation related to the Raghunathpur Thermal Power Project. The court dismissed the appeal by Damodar Valley Corporation, and a bank guarantee of Rs 600 crore will also be released.

Bulk Deals

Sterling and Wilson Renewable Energy

Morgan Stanley Asia Singapore Pte, Societe Generale, and Citigroup Global Markets Mauritius have acquired a 2.8% stake in the renewable energy company at an average price of Rs 623 per share. Meanwhile, promoters Shapoorji Pallonji & Company sold a 5.78% stake at an average price of Rs 623.28 per share, and Khurshed Yazdi Daruvala offloaded 1.35% of his shares at an average price of Rs 630.01 per share.

Shivalik Bimetal Controls

Promoters Ultra Portfolio Management, Angad Estates, Amar Engineering Company, and B.S. Sandhu & Associates sold a 17.97% stake in the company at an average price of Rs 610.6 per share, amounting to Rs 632.1 crore. However, Aditya Birla Sun Life Mutual Fund, UTI Mutual Fund, SBI Mutual Fund, Sundaram Mutual Fund, HSBC Mutual Fund, Franklin Templeton Mutual Fund, DSP Mutual Fund, and Ashoka India Equity Investment Trust Plc collectively acquired a 16.76% stake at the same price, valued at Rs 589.58 crore.

Nuvama Wealth Management

Global investors Morgan Stanley Asia Singapore Pte, Goldman Sachs Funds - Goldman Sachs India Equity Portfolio, and Smallcap World Fund Inc. acquired a 5.2% stake in Nuvama at an average price of Rs 6,702.60 per share, valued at Rs 1,234.8 crore. However, investors EDEL Finance Company and Ecap Equities sold a 6.2% stake in Nuvama at the same price, amounting to Rs 1,481.2 crore.

Entero Healthcare Solutions

Prasid Uno Family Trust sold a 5.5% stake in Entero at an average price of Rs 1,305 per share, amounting to Rs 313.2 crore, while Stichting Depositary APG Emerging Markets Equity Pool bought a 2.1% stake at the same price, valued at Rs 121 crore.

Amrutanjan Health Care

Promoter Nageswaramma Private Trust sold a 1.17% stake in Amrutanjan Health at an average price of Rs 745.29 per share.

Results Today

Northern Arc Capital

Mainboard Listing on September 30

Manba Finance

SME Listing on September 30

WOL 3D India, Rappid Valves India

Stocks Turn Ex-Dividend

ADS Diagnostic

Sunil Shankar Matkar
first published: Sep 29, 2024 09:43 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347